Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1996
03/07/1996WO1996004393A3 Control of plant gene expression
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1996003515A3 Surface expression of enzyme in gene directed prodrug therapy
03/07/1996WO1996003509A3 Insect viruses, sequences, insecticidal compositions and methods of use
03/07/1996WO1996003506A3 Analog of haemophilus hin47 with reduced protease activity
03/07/1996WO1996002641A3 Materials and methods relating to the diagnosis and prophylactic and therapeutic treatment of synovial sarcoma
03/07/1996WO1995032291A3 Hepatitis g virus and molecular cloning thereof
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996DE19531931A1 Modulatoren des Körpergewichts, korrespondierende Nukleinsäuren und Proteine, und diagnostische und therapeutische Verwendungen derselben Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/07/1996CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides
03/07/1996CA2198891A1 Genetically modified t cells
03/07/1996CA2198780A1 Diagnostic test using fc receptor
03/07/1996CA2198757A1 Device for use in the isolation of a biological material such as nucleic acid
03/07/1996CA2198587A1 Trophic factors for central nervous system regeneration
03/07/1996CA2198489A1 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface
03/07/1996CA2198474A1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198473A1 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
03/07/1996CA2198472A1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198451A1 Transgenic animal expressing a familial form of human amyloid precursor protein
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/07/1996CA2198080A1 Cell cycle regulated repressor and dna element
03/07/1996CA2197901A1 Reduction of nonspecific hybridization by using novel base-pairing schemes
03/07/1996CA2197777A1 Novel ribozymes and novel ribozyme selection systems
03/07/1996CA2197774A1 A method of selecting pluripotent hematopoietic progenitor cells
03/07/1996CA2197452A1 Methods and test kits for specific and sensitive diagnosing of periodontal diseases
03/07/1996CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
03/07/1996CA2183649A1 Method for increasing plasmid yield
03/07/1996CA2174844A1 Arabinoxylan degrading enzymes
03/06/1996EP0699768A1 Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
03/06/1996EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4
03/06/1996EP0699765A1 DNA, constructs, cells and plants derived therefrom
03/06/1996EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer
03/06/1996EP0699763A1 Nucleic acid sequence encoding trypsin-like enzyme and process for producing the enzyme
03/06/1996EP0699762A2 Novel Phytase
03/06/1996EP0699761A2 Heptaprenyl diphosphate synthesizing enzyme and dna encoding same
03/06/1996EP0699760A1 Purified DNA polymerase from bacillus stearothermophilus
03/06/1996EP0699759A1 Variant aspartokinase gene
03/06/1996EP0699758A1 Prototype felv isolates for use in disease models and vaccines
03/06/1996EP0699757A1 Potyvirus coat protein genes and plants transformed therewith
03/06/1996EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas
03/06/1996EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them
03/06/1996EP0699754A1 Method for diagnosing a predisposition for breast and ovarian cancer
03/06/1996EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses
03/06/1996EP0699752A2 Mutated recombinant collagens
03/06/1996EP0699751A1 Antisense complementary to HCV genome
03/06/1996EP0699750A1 A collection of phagemids, a collection of Escherichia coli cells carrying the phagemids, a collection of phagemid particles produced from said collection and phagemid particles obtained according to the process
03/06/1996EP0699749A1 Recombinant cycloisomaltooligosaccharide synthase, DNA encoding it, and its use
03/06/1996EP0699748A2 Decreased hydrogen sulfide formation in beer production
03/06/1996EP0699248A1 Methods for treating non-cotton-containing fabrics with cellulase
03/06/1996EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors
03/06/1996EP0699239A1 Genetic stabilizing elements
03/06/1996EP0699238A1 Dna encoding two fish neuropeptides
03/06/1996EP0699237A1 Anti-egfr single-chain fvs and anti-egfr antibodies
03/06/1996EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof
03/06/1996EP0699208A1 Novel peptide nucleic acids
03/06/1996EP0699079A1 Bioactive and/or targeted dendrimer conjugates
03/06/1996EP0699077A1 Hiv immunogenic complexes
03/06/1996EP0699076A1 Otitis media vaccine
03/06/1996EP0699071A1 Anti-viral guanosine-rich oligonucleotides
03/06/1996EP0699023A1 Enhanced insect resistance in plants genetically engineered with a plant hormone gene involved in cytokinin biosynthesis
03/06/1996EP0677194A4 Oligoprobe designstations: a computerized method for designing optimal oligonucleotide probes and primers.
03/06/1996EP0652769B1 Vaccines against metazoan parasites
03/06/1996EP0620853B1 Materials and methods for biosynthesis of serine and serine-related products
03/06/1996EP0479899B1 Vasodilatory and immune suppressant peptides
03/06/1996EP0476059B1 Methods for enhancing the rate of modification of metastable bonds
03/06/1996EP0395653B1 Synovial phospholipases
03/06/1996EP0387319B1 Secretory leader sequences
03/06/1996EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method
03/06/1996EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same
03/06/1996CN1118172A Oxidatively stable alpha-amylase
03/06/1996CN1118168A Structured copolymers used as absorbents, gels and carriers of metal ions
03/06/1996CN1118131A An enzyme feed additive and animal feed including it
03/06/1996CN1118008A Erythropoietin for human
03/06/1996CN1117873A Usage of follicle-stimulating hormone
03/06/1996CA2157531A1 Htfiiia gene
03/05/1996US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev
03/05/1996US5496934 Nucleic acids encoding a cellulose binding domain
03/05/1996US5496926 Process of preparing a soluble LDL receptor
03/05/1996US5496732 Dna sequence encoding isopentenyl transferase
03/05/1996US5496731 Anti-oncogenes
03/05/1996US5496724 Genes encoding platelet aggregation inhibitors
03/05/1996US5496721 Methods of generating desired amino-terminal residues in proteins
03/05/1996US5496720 Increasing intracellular calcium levels; phosphorylation prevention
03/05/1996US5496714 Modification of protein by use of a controllable interveining protein sequence
03/05/1996US5496713 Process for producing 20 kD human growth hormone
03/05/1996US5496711 Genetic engineering with dna using fungi, yeasts and bacteria
03/05/1996US5496699 Dna deproteinizing with enzymes, denaturing strands, amplification of mutant allele and primers
03/05/1996US5496698 Method of isolating ribozyme targets
03/05/1996US5496562 Solid medium and method for DNA storage
03/05/1996CA1338122C Tissue factor inhibitor of coagulation
03/04/1996EP0711347A4 Ph genes and their uses
02/1996
02/29/1996WO1996006191A2 Primers and probes for the amplification and detection of cmv nucleic acid
02/29/1996WO1996006190A2 Coupled amplification and ligation method
02/29/1996WO1996006188A1 Peptide librairies as a source of syngenes
02/29/1996WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations
02/29/1996WO1996006176A1 Functional modified hsv1-tk
02/29/1996WO1996006175A2 Fumonisin-detoxifying enzymes
02/29/1996WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
02/29/1996WO1996006173A1 Genetic manipulation of plants to increase stored carbohydrates